Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 716-718

  Quezada, Gerardo ^a   Koshkina, Nadezhda V ^a   Zweidler McKay, Patrick ^a   Zhou, Zichao ^a   Kontoyiannis, Dimitrios P ^a   Kleinerman, Eugenie S ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Box 87 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CORTISONE ACETATE; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LUNG ASPERGILLOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, FUNGAL; MICE; TREATMENT OUTCOME;

EID: 38649100021     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00760-07     Document Type: Article

References (20)

1. Anderson, P. M., S. N. Markovic, J. A. Sloan, M. L. Clawson, M. Wylam, C. A. Arndt, W. A. Smithson, P. Burch, M. Gornet, and E. Rahman. 1999. Aerosol GM-CSF: a low toxicity, lung-specific biological therapy in patients with lung metastasis. Clin. Cancer Res. 5:2316-2323.
2. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805.
3. Bowman, J. C., G. K. Abruzzo, J. W. Anderson, A. M. Flattery, C. J. Gill, V. B. Pikounis, D. M. Schmatz, P. A. Liberator, and C. M. Douglas. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 45:3474-3481.
4. Brummer, E., A. Maqbool, and D. A. Stevens. 2001. In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages. J. Leukoc. Biol. 70:868-872.
5. Gordon, S. 1999. Macrophage-restricted markers: role in differentiation and activation. Immunol. Lett. 65:5-8.
6. Gordon, S., L. Lawson, S. Rabinowitz, P. R. Crocker, L. Morris, and V. H. Perry. 1992. Antigen markers of macrophage differentiation in murine tissues. Curr. Top. Microbiol. Immunol. 181:1-37.
7. Gudmundsson, S., and H. Erlenddottir. 1999. Murine thigh infection model, p. 137-144. In O. Zak and M. A. Sande (ed.), Handbook of animal models of infection, 1st ed. Academic Press, San Diego, CA.
8. Hume, D. A., and S. Gordon. 1983. Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: identification of resident macrophages in renal medullary and cortical interstitium and the juxtaglomerular complex. J. Exp. Med. 157:1704.
9. Kontoyiannis, D. P., and G. P. Bodey. 2002. Invasive aspergillosis in 2002: an update. Eur. J. Clin. Microbiol. Infect. Dis. 21:161-172.
10. Lewis, R. E., R. A. Prince, and D. P. Kontoyiannis. 2002. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive aspergillosis. Antimicrob. Agents Chemother. 46:3208-3214.
11. Lewis, R. E., and N. P. Wiederhold. 2005. Murine model of invasive aspergillosis. Methods Mol. Med. 118:129-142.
12. Lewis, R. E., G. Liao, J. Hou, G. Chamilos, R. A. Prince, and D. P. Kontoyiannis. 2007. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 51:1253-1258.
13. Rao, R. D., P. M. Anderson, C. A. Arndt, P. J. Wettstein, and S. N. Markovic. 2003. Aerosolized GM-CSF therapy in metastatic cancer. Am. J. Clin. Oncol. 26:493-498.
14. Roilides, E., C. Blake, A. Holmes, P. A. Pizzo, and T. J. Walsh. 1996. Granulocyte-macrophage colony-stimulating factor and interferon-γ prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J. Med. Vet. Mycol. 34:63-69.
15. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J. Infect. Dis. 170:894-899.
16. Sionov, E., and E. Segal. 2003. Polyene and cytokine treatment of experimental aspergillosis. FEMS Immunol. Med. Microbiol. 39:221-227.
17. Tazawa, R., K. Nakata, Y. Inoue, and T. Nukiwa. 2006. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Respirology 11(Suppl.):S61-S64.
18. Vora, S., S. Chauhan, E. Brummer, and D. A. Stevens. 1998. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrob. Agents Chemother. 42:2299-2303.
19. Wiederhold, N. P., D. P. Kontoyiannis, J. Chi, R. A. Prince, V. H. Tam, and R. E. Lewis. 2004. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J. Infect. Dis. 190:1464-1471.
20. Wylam, M. E., R. Ten, U. B. Prakash, H. F. Nadrous, M. L. Clawson, and P. M. Anderson. 2006. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur. Respir. J. 27:585-593.